Lung cancer: open trials in Taiwan

144 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Trial Treatment · Phase 1/2 · Inhibrx Biosciences, Inc
Changhua Christian Hospital (CCH), Changhua · E-Da Cancer Hospital, Kaohsiung City · Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), Kaohsiung City · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei
Registry updated 2026-11-06
NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Chung Shan Medical University Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-11-06
NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
China Medical University Hospital, Taichung · Veterans General Hospital - Taichung, Taichung · Chi Mei Hospital, Liouying, Tainan · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · Linkou Chang Gung Memorial Hospital, Taoyuan
Registry updated 2026-11-06
NCT06881784
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Trial Treatment · Phase 3 · Revolution Medicines, Inc.
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Taipei Medical University Hospital, Taipei · Chang Gung Medical Foundation - Linkou, Taoyuan
Registry updated 2026-11-06
NCT07699328
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 1/2 · Voronoi, Inc
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Taiwan University Hospital, Taipei · Taipei Medical University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-11-06
NCT05789082
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan Uni Hospital, Taipei · Chang Gung Medical Foundation - Linkou, Taoyuan
Registry updated 2026-11-05
NCT06793215
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Hoffmann-La Roche
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · E-DA Hospital, Kaohsiung City · Chung Shan Medical University Hospital, Taichung · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · Taipei Medical University Hospital, Taipei · National Taiwan University Cancer Center, Zhongzheng Dist.
Registry updated 2026-11-05
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Pfizer
Changhua Christian Hospital, Changhua County · Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-11-05
NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Far Eastern Memorial Hospital, New Taipei City · Taichung Veterans General Hospital, Taichung · National Taiwan University Hospital, Taipei · National Taiwan University Hospital - Hsinchu branch, Zhubei
Registry updated 2026-11-05
NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Changhua Christian Hospital, Changhua County · Buddhist Dalin Tzu Chi General Hospital, Chiayi City · National Taiwan University Hospital Yun-Lin Branch Dou-Liou Region, Douliu · Hualien Tzu Chi Medical Center, Hualien City · Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist · New Taipei Municipal TuCheng Hospital, New Taipei City · Chung Shan Medical University Hospital, Taichung · Taichung Veterans General Hospital, Taichung · Chi Mei Medical Center, Tainan · National Cheng Kung University Hospital, Tainan · Chi Mei Hospital - Liouying Branch, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Cancer Center (NTUCC), Taipei · National Taiwan University Hospital, Taipei · Chang Gung Medical Foundation-Linkou Branch, Taoyuan · National Taiwan University Hospital - Hsinchu branch, Zhubei
Registry updated 2026-11-04
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 3 · Bayer
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · Chung Shan Medical University Hospital, Taichung · Chi-Mei Medical Center, Liouyine, Tainan · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital (NTUH) - Cancer Research Center, Taipei
Registry updated 2026-11-04
NCT06706076
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Trial Treatment · Phase 1/2 · BlossomHill Therapeutics
Taichung Veterans General Hospital, Taichung · National Taiwan University Cancer Center, Taipei · National Taiwan University Hospital, Taipei
Registry updated 2026-11-04
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Changhua Christian Hospital, Changhua County · Buddhist Dalin Tzu Chi General Hospital, Chiayi City · National Taiwan University Hospital Yun-Lin Branch Dou-Liou Region, Douliu · Hualien Tzu Chi Medical Center, Hualien City · Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · E-DA Hospital, Kaohsiung City · Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist · Far Eastern Memorial Hospital, New Taipei City · New Taipei Municipal TuCheng Hospital, New Taipei City · Taichung Veterans General Hospital, Taichung · Chung Shan Medical University Hospital, Taichung · Chi Mei Hospital - Liouying Branch, Tainan · National Cheng Kung University Hospital, Tainan · Chi Mei Medical Center, Tainan · National Taiwan University Hospital, Taipei · Taipei Medical University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · National Taiwan University Cancer Center (NTUCC), Taipei · Chang Gung Medical Foundation-Linkou Branch, Taoyuan
Registry updated 2026-11-04
NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
National Taiwan University Hospital - Hsinchu branch (Site 3901), Hsinchu · Kaohsiung Medical University Chung-Ho Memorial Hospital (Site 3904), Kaohsiung City · Chang Gung Memorial Hospital at Kaohsiung (Site 3902), Kaohsiung City · Taipei Medical University Shuang Ho Hospital (Site 3912), New Taipei City · Taichung Veterans General Hospital-Chest (Site 3905), Taichung · National Cheng Kung University Hospital-Clinical Trial Center (Site 3903), Tainan · Chi Mei Hospital - Liouying Branch (Site 3908), Tainan · Chi Mei Medical Center (Site 3915), Tainan · Mackay Memorial Hospital (Site 3909), Taipei · National Taiwan University Hospital-Oncology (Site 3906), Taipei · National Taiwan University Cancer Center (NTUCC) (Site 3907), Taipei City
Registry updated 2026-11-03
NCT07288177
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Trial Treatment · Phase 2 · Genmab
Changhua Christian Hospital, Changhua · Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City · Chi Mei Medical Center - Liouying, Tainan · National Cheng Kung University, Tainan · National Taiwan University Hospital NTUH, Taipei
Registry updated 2026-11-03
NCT07586202
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Taichung Veterans General Hospital, Taichung · Chi Mei Medical Center Liouying Branch, Tainan · National Taiwan University Hospital, Taipei · Taipei Medical University Hospital, Taipei · NTU Biomedical Park Hospital, Zhubei
Registry updated 2026-11-03
NCT07185997
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Trial Treatment · Phase 3 · ArriVent BioPharma, Inc.
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Taiwan University Cancer Center, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-11-02
NCT07195695
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Trial Treatment · Phase 3 · Boehringer Ingelheim
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · China Medical University Hospital, Taichung · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · Tri-Service General Hospital, Taipei · Chang Gung Memorial Hospital Linkou, Taoyuan City
Registry updated 2026-11-02
NCT07431827
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Taipei Medical University Shuang Ho Hospital (Site 3700), New Taipei City · National Cheng Kung University Hospital (Site 3706), Tainan · Mackay Memorial Hospital (Site 3701), Taipei · Tri-Service General Hospital (Site 3708), Taipei · National Taiwan University Cancer Center (NTUCC) (Site 3707), Taipei
Registry updated 2026-11-02
NCT07554339
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Taipei Medical University Shuang Ho Hospital (Site 2612), New Taipei City · National Cheng Kung University Hospital (Site 2601), Tainan · Tri-Service General Hospital (Site 2608), Taipei · National Taiwan University Cancer Center (NTUCC) (Site 2610), Taipei · Mackay Memorial Hospital (Site 2611), Taipei
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Local Institution - 007-127, Taichung · Taichung Veterans General Hospital, Taichung · China Medical University Hospital, Taichung · Chi Mei Hospital, Liouying, Tainan · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare, Taipei · National Taiwan University Hospital, Taipei · Chang Gung Memorial Hospital, Linkou Branch, Taoyuan
Registry updated 2026-10-30
NCT06043817
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Trial Treatment · Phase 1/2 · Pierre Fabre Medicament
National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-10-30
NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Far Eastern Memorial Hospital (Site 2362), New Taipei City · China Medical University Hospital (Site 2358), Taichung · Chung Shan Medical University Hospital (Site 2351), Taichung · National Cheng Kung University Hospital (Site 2354), Tainan · Koo Foundation Sun Yat-Sen Cancer Center (Site 2359), Taipei · Taipei Veterans General Hospital (Site 2357), Taipei · Taipei Medical University Hospital (Site 2352), Taipei · Mackay Memorial Hospital (Site 2355), Taipei · National Taiwan University Cancer Center (NTUCC) (Site 2360), Taipei · Chang Gung Memorial Hospital (Site 2361), Taoyuan
Registry updated 2026-10-30
NCT07513376
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Chang Gung Memorial Hospital at Kaohsiung (Site 5302), Kaohsiung City · Taichung Veterans General Hospital (Site 5301), Taichung · China Medical University Hospital (Site 5303), Taichung · National Cheng Kung University Hospital (Site 5300), Tainan · Taipei Medical University Hospital (Site 5305), Taipei
Registry updated 2026-10-30
NCT04165070
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Changhua Christian Hospital (Site 0181), Changhua · Taipei Medical University Hospital (Site 0180), Taipei · Chang Gung Medical Foundation-Linkou Branch (Site 0182), Taoyuan
Registry updated 2026-10-29

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error